Literature DB >> 22120527

Eph receptors at synapses: implications in neurodegenerative diseases.

Yu Chen1, Amy K Y Fu, Nancy Y Ip.   

Abstract

Precise regulation of synapse formation, maintenance and plasticity is crucial for normal cognitive function, and synaptic failure has been suggested as one of the hallmarks of neurodegenerative diseases. In this review, we describe the recent progress in our understanding of how the receptor tyrosine kinase Ephs and their ligands ephrins regulate dendritic spine morphogenesis, synapse formation and maturation, as well as synaptic plasticity. In particular, we discuss the emerging evidence implicating that deregulation of Eph/ephrin signaling contributes to the aberrant synaptic functions associated with cognitive impairment in Alzheimer's disease. Understanding how Eph/ephrin regulates synaptic function may therefore provide new insights into the development of therapeutic agents against neurodegenerative diseases.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120527     DOI: 10.1016/j.cellsig.2011.11.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  32 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  Fluoxetine and Riluzole Mitigates Manganese-Induced Disruption of Glutamate Transporters and Excitotoxicity via Ephrin-A3/GLAST-GLT-1/Glu Signaling Pathway in Striatum of Mice.

Authors:  Zhipeng Qi; Xinxin Yang; Yanqi Sang; Yanan Liu; Jiashuo Li; Bin Xu; Wei Liu; Miao He; Zhaofa Xu; Yu Deng; Jinghai Zhu
Journal:  Neurotox Res       Date:  2020-05-29       Impact factor: 3.911

3.  Ephrin/Ephrin receptor expression in ammonia-treated rat astrocytes and in human cerebral cortex in hepatic encephalopathy.

Authors:  Karmela Sobczyk; Markus S Jördens; Ayse Karababa; Boris Görg; Dieter Häussinger
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

4.  Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease.

Authors:  Amy K Y Fu; Kwok-Wang Hung; Huiqian Huang; Shuo Gu; Yang Shen; Elaine Y L Cheng; Fanny C F Ip; Xuhui Huang; Wing-Yu Fu; Nancy Y Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

Review 5.  Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.

Authors:  Roger Lefort
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 6.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

Review 7.  EphBs: an integral link between synaptic function and synaptopathies.

Authors:  Sean I Sheffler-Collins; Matthew B Dalva
Journal:  Trends Neurosci       Date:  2012-04-18       Impact factor: 13.837

Review 8.  Instructive roles of astrocytes in hippocampal synaptic plasticity: neuronal activity-dependent regulatory mechanisms.

Authors:  Ye Wang; Amy K Y Fu; Nancy Y Ip
Journal:  FEBS J       Date:  2021-05-10       Impact factor: 5.622

9.  Axin Regulates Dendritic Spine Morphogenesis through Cdc42-Dependent Signaling.

Authors:  Yu Chen; Zhuoyi Liang; Erkang Fei; Yuewen Chen; Xiaopu Zhou; Weiqun Fang; Wing-Yu Fu; Amy K Y Fu; Nancy Y Ip
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

Review 10.  The role of proteases in regulating Eph/ephrin signaling.

Authors:  Lakmali Atapattu; Martin Lackmann; Peter W Janes
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.